Multilateral Health Diplomacy of Indonesia through Indonesia’s Leadership in the G20 Forum during COVID-19 Pandemic

Sindy Yulia Putri, Yuliani Widianingsih, Nurmasari Situmeang

Abstrak


This research analyzes Indonesia’s implementation of multilateral health diplomacy (HD) during the COVID-19 crisis, with emphasis on its leadership in the 2022 G20 Presidency. Using a qualitative case study approach based on secondary data, this research examines “How did the Indonesian government implement multilateral HD at the G20 to strengthen global health architecture and resilience during the COVID-19 pandemic?” The findings described that Indonesia adopted a multi-level diplomatic strategy involving government ministries, international organizations, regional institutions, and national pharmaceutical industries (Bio Farma). Through these collaborations, Indonesia successfully advocated equitable access to vaccines, strengthened global health governance, and advanced pandemic preparedness. Key initiatives—including the establishment of the Pandemic Fund, co-chairmanship of the COVAX AMC Engagement Group, and development of the One Health framework—demonstrate Indonesia’s growing role as an emerging power in GHD. This study contributes to the operationalization of GHD theory by describing health diplomacy strategies that bridge national interests and global solidarity in a multilateral context in facing current and future pandemics.


Penelitian ini menganalisis implementasi diplomasi kesehatan multilateral Indonesia selama krisis COVID-19 dengan penekanan pada presidensi Indonesia di G20 tahun 2022. Dengan menggunakan pendekatan studi kasus kualitatif berdasarkan data sekunder, penelitian ini mengkaji “Bagaimana pemerintah Indonesia menerapkan diplomasi kesehatan multilateral di G20 untuk memperkuat arsitektur dan ketahanan kesehatan global selama pandemi COVID-19?” Temuan penelitian ini menggambarkan bahwa Indonesia mengadopsi strategi diplomasi multi-tingkat yang melibatkan kementerian, institusi regional dan internasional, industri farmasi nasional (Bio Farma). Melalui kolaborasi ini, Indonesia berhasil mengadvokasi akses vaksin yang adil, memperkuat tata kelola kesehatan global, dan memajukan kesiapsiagaan pandemi. Inisiatif-inisiatif utama–termasuk pembentukan Dana darurat pandemi, keterlibatan dalam COVAX AMC Engagement Group, dan pengembangan kerangka kerja One Health–menunjukkan peran Indonesia yang semakin besar sebagai emerging power di ranah GHD. Riset ini berkontribusi pada operasionalisasi teori GHD dengan menggambarkan strategi diplomasi kesehatan yang menjembatani kepentingan nasional dan solidaritas global pada konteks multilateral dalam menghadapi pandemi di masa kini dan mendatang.

Kata Kunci


COVID-19; G20; Indonesia’s Leadership; Multilateral Health Diplomacy

Teks Lengkap:

PDF (English)

Referensi


Ahmada, S. F. (2024). Indonesia Interest toward G20 Pandemic Fund: Global Health Diplomacy Perspective. Jurnal Hubungan Internasional, 17(1), 62–77.

Almeida, C. (2020). Global Health Diplomacy: A Theoretical and Analytical Review. In Oxford Research Encyclopedia of Global Public Health. Oxford University Press. https://doi.org/10.1093/acrefore/9780190632366.013.25

Alwan, A. (2014). Summary of the Third Seminar on Health Diplomacy (WHO-EM/HHR/003/).

Amul, G. G., Ang, M., Kraybill, D., Ong, S. E., & Yoong, J. (2022). Responses to COVID-19 in Southeast Asia: Diverse Paths and Ongoing Challenges. In Asian Economic Policy Review (Vol. 17, Issue 1, pp. 90–110). John Wiley and Sons Inc. https://doi.org/10.1111/aepr.12362

Bachmann, V. (2019). (Trans)regionalism and South-South cooperation: Afrasia instead of Eurafrique? Third World Quarterly, 0(0), 1–21. https://doi.org/10.1080/01436597.2019.1573634

Bio Farma. (n.d.-a). Bio Farma: About Us. Bio Farma Group.

Bio Farma. (n.d.-b). Bio Farma, WHO, MPP and Cepi Collaborate To Increase Vaccine Accessibility In The Global South Region. https://medicinespatentpool.org/

Bio Farma. (2022). Phase 3 Clinical Trial of Bio Farma’s Covid-19 Vaccine Commencing Soon, Indonesia Will Be Independent in Making Covid-19 Vaccine. Bio Farma, 1–7.

Bio Farma. (2024, October 17). Memberikan Kontribusi Aktif di Masa Pandemi: Peneliti Bio Farma Menerima Penghargaan dari Kemenkes RI.

Birn, A. E., Muntaner, C., & Afzal, Z. (2017). South-South cooperation in health: Bringing in theory, politics, history, and social justice. In Cadernos de Saude Publica (Vol. 33). Fundacao Oswaldo Cruz. https://doi.org/10.1590/0102-311X00194616

Bjola, C., & Coplen, M. (2023). Digital Diplomacy in the Time of the Coronavirus Pandemic: Lessons and Recommendations. Studies in Diplomacy and International Relations, 323–342. https://doi.org/10.1007/978-3-031-10971-3_16

Bradford, C. I., & Coulibaly, B. S. (2025). Strengthening Cooperation For A Changing World: The Evolving Role Of The G20 In Global Economic Governance. Global Economy and Development at Brookings, 1–26.

Davies, S. E., Elbe, S., Howell, A., & McInnes, C. (2014). Global health in international relations: Editors’ introduction. In Review of International Studies (Vol. 40, Issue 5, pp. 825–834). Cambridge University Press. https://doi.org/10.1017/S0260210514000308

Dellepiane, N., & Wood, D. (2015). Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives. Vaccine, 33(1), 52–61.

Denzin, N. K., & Lincoln, Y. S. (2018). The SAGE Handbook of Qualitative Research. SAGE Publications Inc.

Djalal, D. P., Subagyo, A., & Delanova, M. O. (2021). Health Diplomacy as an Instrument of Indonesian Foreign Policy in the Era of Covid-19 Pandemic. Journal of Global Strategic Studies, 1(2), 1–17. https://ejournal.fisip.unjani.ac.id/index.php/JGSS/article/view/849/294

Drager, N., David, &, & Fidler, P. (2007). Foreign Policy, Trade and Health: At the Cutting Edge of Global Health Diplomacy. In Bulletin of the World Health Organization (Vol. 85, Issue 3).

ERIA. (2022). [Op-ed] Indonesia’s Challenge in Reviving G20 for (a stronger and inclusive) Global Economic Recovery. Economic Research Institute for ASEAN and East Asia, 1–6. https://www.eria.org/database-and-programmes/op-ed-indonesias-challenge-in-reviving-g20-for-a-stronger-and-inclusive-global-economic-recovery

Febreani, Y. K. (2022). Penguatan Kerjasama ASEAN Plus Three (APT) untuk Penanganan dan Mitigasi Dampak Negatif Ekonomi dari Pandemi Covid-19. Jurnal Hubungan Internasional, 15(1), 1–19. https://doi.org/10.20473/jhi.v15i1.31254

Fidler, D. P. (2010). Asia’s Participation in Global Health Diplomacy and Global Health Governance. Asian Journal of WTO & International Health Law and Policy, 1–33.

G20 Task Force. (2022a). G20 Bali Leaders-Declaration. 1–19. https://g20.utoronto.ca/2022/G20%20Bali%20Leaders-%20Declaration,%2015-16%20November%202022,%20incl%20Annex.pdf

G20 Task Force. (2022b). G20 Health Ministers’ Action to Strengthen Global Health Architecture. https://g7g20-documents.org/fileadmin/G7G20_documents/2022/G20/Indonesia/Sherpa-Track/Health%20Ministers/1%20Ministers’%20Language/Chair%E2%80%99s%20Summary%20Health%20Ministers’%20Meeting%20of%20the%20G20_28102022.pdf

G20 Task Force. (2022c). The Lombok G20 One Health Policy Brief Context. https://www.consilium.europa.eu/media/52730/g20-leaders-declaration-final.pdf

G20 Working Group. (2022). G20 Presidency Chair’s Summary. The Second G20 Joint Finance and Health Ministers’ Meeting.

Gill, B. (2020). China’s Global Influence: Post-COVID Prospects for Soft Power. The Washington Quarterly, 43, 97–115.

Harini, F. (2022). G20 Sepakati Pandemic Fund, Kantongi Komitmen US$1,4 Miliar. VALIDNEWS, 1–3.

Hosseinpoor, A. R., Nambiar, D., Tawilah, J., Schlotheuber, A., Briot, B., Bateman, M., Davey, T., Kusumawardani, N., Myint, T., Nuryetty, M. T., Prasetyo, S., Suparmi, & Floranita, R. (2018). Capacity building for health inequality monitoring in Indonesia: enhancing the equity orientation of country health information system. Global Health Action, 11. https://doi.org/10.1080/16549716.2017.1419739

Inayah, A., Hadiawan, A., & Asnasari, T. K. (2023). Study of Indonesian Vaccine Diplomacy at Bilateral, Regional, and Multilateral Levels to Overcome Covid-19 Pandemic. KnE Social Sciences, 8(5), 217–235. https://doi.org/10.18502/kss.v8i5.13000

Jakarta Globe. (2022). Indonesia Set to Become mRNA-Based Vaccine Production Hub for Southeast Asia. Jakarta Globe, 1–5.

Jose, H. S., & Putri, I. P. E. (2021). Tatanan Global Pada Pembangunan Dan Ekonomi Politik Internasional Selama Dan Pasca Pandemi Covid-19. Jurnal Ilmiah Penalaran Dan Penelitian Mahasiswa, 5(1), 46–70. https://www.researchgate.net/publication/352038619_Tatanan_Global_Pada_Pembangunan_Dan_Ekonomi_Politik_Internasional_Selama_Dan_Pasca_Pandemi_COVID-19

Kadewandana, D. (2021). Indonesian Foreign Policy and the COVID-19 Pandemic. Foreign Policy Review, 14(3), 44–59. https://doi.org/10.47706/kkifpr.2021.3.44-59

Katz, R., Kornblet, S., Arnold, G., Lief, E., & Fischer, J. E. (2011). Defining Health Diplomacy: Changing Demands in the Era of Globalization. The Milbank Quarterly, 89(3), 1–21.

Kelly, L. (2021). Characteristics of Global Health Diplomacy. K4D (Knowledge, Evidence, and Learning for Development), 1–12.

Khazatzadeh-Mahani, A., Ruckert, A., & Labonte, R. (2018). Global health diplomacy. Oxford University Press, 1–24. https://doi.org/10.1093/oxfordhb/9780190456818.013.7

Kickbusch, I., Liu, A., Kazatchkine, M., & Kökény, M. (2022). Global health diplomacy—reconstructing power and governance. In Global Health Centre. Elsevier B.V. https://doi.org/10.1016/S0140-6736(22)00583-9

Kickbusch, I., & Told, M. (2013). 21st Century Global Health Diplomacy (T. E. Novotny, Ed.; Vol. 3). World Scientific Publishing.

Kuriakose, S. (2020). Global Health: Global Health Diplomacy. Journal of Global Health, 10(2), 1–5. https://doi.org/10.7189/jogh.10.020354

Lal, A., Abdalla, S. M., Chattu, V. K., Erondu, N. A., Lee, T. L., Singh, S., Abou-Taleb, H., Vega Morales, J., & Phelan, A. (2022). Pandemic preparedness and response: exploring the role of universal health coverage within the global health security architecture. In The Lancet Global Health (Vol. 10, Issue 11, pp. e1675–e1683). Elsevier Ltd. https://doi.org/10.1016/S2214-109X(22)00341-2

Larionova, M. (2023). G20 at the Critical Juncture. Indonesia’s 2022 Presidency: Internal and External Shocks, Risks of Power Rebalancing and Eventual Demise, Causes of Resilience and Re-Equilibrium. International Organisations Research Journal, 18(1). https://doi.org/10.17323/1996-7845-2023-01-02

Lisa. (2020). COVID-19 Vaccine Global Access (COVAX) Facility. 1–32.

Lisbet. (2022). Manfaat Dan Tantangan Presidensi G-20 Indonesia. Pusat Penelitian Badan Keahlian DPR RI, 1–6. https://berkas.dpr.go.id/pusaka/files/info_singkat/Info%20Singkat-XIV-2-II-P3DI-Januari-2022-238.pdf

Mahendradhata, Y., Andayani, N. L. P. E., Hasri, E. T., Arifi, M. D., Siahaan, R. G. M., Solikha, D. A., & Ali, P. B. (2021). The Capacity of the Indonesian Healthcare System to Respond to COVID-19. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.649819

Maryadi, L. H. P., Dewi, E. D., Aryadi, T., Santikajaya, A., Fitri, W., & Putri, R. A. (2018). “Kesehatan untuk Semua: Strategi Diplomasi Kesehatan Global Indonesia” Kajian Mandiri Tahun 2018. Badan Pengkajian dan Pengembangan Kebijakan Kementerian Luar Negeri Republik Indonesia.

McBride, B., Hawkes, S., & Buse, K. (2019). Soft power and global health: The sustainable development goals (SDGs) era health agendas of the G7, G20 and BRICS. BMC Public Health, 19(1). https://doi.org/10.1186/s12889-019-7114-5

Ministry of State Secretariat. (2020). Peraturan Pemerintah Pengganti Undang-Undang Republik Indonesia Nomor 1 Tahun 2o2o. 1–46.

MoFA of Indonesia. (2022). Laporan Kinerja Kementerian Luar Negeri Republik Indonesia. Ministry of Foreign Affairs of Indonesia, 1–286. www.kemlu.go.id

Naqsabandiyah, A. H., Arfah, M. I., & Al-Ayubi, M. S. (2022). Indonesia’s Contributive Role in the G20 to Mitigate the COVID-19 Pandemic. In Indonesia Post-Pandemic Outlook: Social Perspectives (pp. 9–34). BRIN. https://doi.org/10.55981/brin.536.c459

Neuman, W. L. (William L. (2014). Social Research Methods: Qualitative and Quantitative Approaches.

Nishizawa, H., Nishimura, Y., Matsumura, H., Horiuchi, H., Higashira, T., Kita, Y., Sahara, Y., & Suzuki, Y. (2020). G20 Okayama Health Ministers’ meeting: Conclusions and commitments. Journal of Global Health, 10(1). https://doi.org/10.7189/jogh.10.010320

Rakhra, K. (2023). The G20 as a Multilateral Force. CEBRI Journal, 8, 77–94.

Ravi, S., Meyer, D., Snyder, M., Mullen, L., & Warmbrod, L. (2019). 2019 Global Health Security Index. Center for Health Security: Johns Hopkins Bloomberg School of Public Health, 1–324.

Rosenbaum, P., Rehn, C., Wennberg, K., Nordström, A., & Alfvén, T. (2025). Navigating global health diplomacy: challenges and opportunities in building a community of practice. Globalization and Health, 21(1). https://doi.org/10.1186/s12992-025-01100-z

Roza, R. (2022). The Focus Of Indonesian Diplomacy In 2022 And The Diplomatic Role Of The Indonesian House Of Representatives. Info Singkat, XIII(1), 1–6. https://berkas.dpr.go.id/pusaka/files/info_singkat/Info%20Singkat-XIV-1-I-P3DI-Januari-2022-244-EN.pdf

Sari, D. S., Halimah, M., Akim, A., Maximillian, R., Muawal, F. S., & Lie, N. J. (2024). Strategic Health Diplomacy: An Indonesia’s Approach in Securing COVID-19 Booster Vaccine Supplies. Jurnal Hubungan Internasional, 13(1), 17–30. https://doi.org/10.18196/jhi.v13i1.17829

Setiawan, I. (2021, January 25). Bio Farma Akan Produksi 4,7 Juta dosis Vaksin Covid-19 untuk Digunakan Pada bulan Februari 2021. Bio Farma.

Urrieta, L., & Hatt, B. (2019). Qualitative Methods and the Study of Identity and Education. Oxford Research Encyclopedia of Education. https://doi.org/10.1093/acrefore/9780190264093.013.550

Wicaksono, R. M. T. A. D., Hirawan, F. B., & Ragamustari, S. K. (2022). An Analysis of Indonesia’s Free and Active COVID-19 Vaccine Diplomacy. Jurnal Hubungan Internasional, 11(1), 32–45. https://doi.org/10.18196/jhi.v11i1.13087

Youde, J. (2010). China’s Health Diplomacy in Africa. China: An International Journal, 08(01), 151–163. https://doi.org/10.1142/S0219747210000099

Youde, J. (2016). High Politics, Low Politics, and Global Health. Journal of Global Security Studies, 1(2), 157–170.




DOI: https://doi.org/10.24198/padjir.v8i1.49353

Padjadjaran Journal of International Relations Terindeks Di:

 Google Scholar   Indonesia One SearchWorldCat Crossref  Bielefeld Academic Search Engine (BASE)